Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2020

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Clinical trial Intelligence for contract research organizations

We help CROs win business and enhance drug development services. Make better-informed decisions while bidding on and implementing clinical trials.

The key to trial success

There are some trials that could be great for your business and others that might not be. But without high-quality intelligence, it can be hard to assess or maximize a trial’s potential.

How we help
Our thorough and extensive clinical trial intelligence for CROs will help your organization:

Identify clinical trials that may be completing, as well as company’s planned clinical trials
Make the right go/no-go decision
Design clinical trials that eliminate the need for additional trials, avoiding extra costs
Quickly identify and generate your short list of investigators

We’ll help you identify companies active in your territory and their phases of development. Spot where to run trials, with our data on where comparator trials have been approved and the availability of regional investigators.

You can size up competing trials, because we monitor and benchmark them, prioritizing investigators and tracking enrollment. And to help you mitigate risks, we can provide intelligence on safety issues faced by trials of similar designs.

Our unique strengths

Position your organization to win more business

Helping with everything from lead generation to targeting, proposal preparation to feasibility assessments and bid defenses, our intelligence will help you secure more successful trials.

Find trial-experienced investigators globally

Use the industry’s best source for checking investigator availability in regions, as well as prioritizing and targeting investigators with the right trial experience.

Set your trials up for approval

Shorten the timeline to protocol submission and approval with our clinical trials research and intelligence.

Make better informed decisions

Use our intelligence to inform the design of your clinical trials, bringing efficiencies to the process.

Benefit from a dedicated service

Our services come with dedicated client service and analyst support.

View more
View Less

Relevant products

Citeline

Citeline Engage: Supporting clinical trial planning and execution right from the start

Recruit the right investigators, optimize your study protocol, and ignite awareness of your clinical trial

Key benefits:

Citeline Engage: Recruit
Citeline Engage: Optimize
Citeline Engage: Ignite

Pharmaprojects: track pharma R&D

The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for 35+ years. With 68,000+ drug profiles including 15,000 drugs in active development, it’s the go-to resource for preclinical, clinical, and pipeline coverage, and lifecycle management tracking.

Key benefits:

Curated by experts
Drug R&D landscape
Historical trends

View all content

Citeline

Adoptive Cell Therapy

03 Feb 2020

Citeline recently introduced a new Therapeutic Class called "Adoptive cell therapy", enabling more granular searching capabilities to hone in on this exciting cancer immunotherapy that is expanding the horizon of personalized medicine

Topic Cell and gene therapy

View infographic
Citeline

Breast Cancer Clinical Landscape and Recent Trends Whitepaper

10 Jan 2020

Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.

Topic Cancer Clinical Trials Research

View white paper
Trialtrove

Trialtrove 2018 Clinical Trials Roundup Surveying the Landscape of 2018 Trial Starts infographic

21 Nov 2019

A clear view of the past is often the surest way to plan for the future. The annual analysis of Phase I-III clinical trials from Citeline’s Trialtrove reveals the priorities and strategies of the biopharma industry. This infographic lets you clearly see the players, trials, and trends.

Topic Drug Development Landscape BioPharmaceutical Business Strategies

View article
Citeline Engage

Citeline Engage: Recruit

By Pharma Intelligence 15 Nov 2019

Case Study: A Top 5 CRO partners with Informa Pharma Intelligence to mitigate risk, identify and recruit untapped investigators, and accelerate timelines

View case study
Trialtrove

Trialtrove's Patient-centric Trials Snapshot

24 Oct 2019

Review the trends, diseases, sponsors and outcomes involved with recent patient-centric clinical trials.

Topic Clinical trials

View infographic
Trialtrove

Snapshot of the patient-centric trial landscape

24 Oct 2019

Patient-centric trials have been growing for years. Backed by data from Citeline’s Trialtrove, our latest infographic reveals the trends, the sponsors, and the impact on outcomes around Phase I, II, and III industry-sponsored, patient-centric trials.

Topic Drug development landscape

View infographic
Trialtrove

2018 Clinical Trials Roundup: Surveying the Landscape of 2018 Trial Starts

11 Oct 2019

See last year’s clinical trial activity through the eyes of our expert analysts and get a better sense of where the industry is headed. This new whitepaper is the annual analysis of Phase I-III clinical trials, from Citeline’s Trialtrove, and reveals the priorities and strategies of the biopharma industry.

Topic Drug development landscape BioPharmaceutical Business strategies

View article
Citeline

Exploring Basket and Umbrella Oncology Trials

26 Sep 2019

To increase flexibility and efficiency in drug development, master protocols have emerged as an innovative clinical trial design, including basket and umbrella trials. Learn more about how these approaches are being used within oncology research through an overview of the clinical landscape, trial outcomes and trends.

Topic Drug development landscape

View infographic
Citeline, Pink Sheet

Clinical Trial Design Report

26 Sep 2019

Rising costs, patient recruitment issues, shifting regulations, and more are making bringing new drugs to market more difficult than ever. Explore changes in clinical trial design being adopted in response to these challenges with reporting from Pink Sheet.

Topic Drug development landscape

Single report
Citeline

QIDP: What have we GAINed?

By Jonathan Slater 02 Sep 2019

The Generating Antibiotic Incentives Now (GAIN) Act passed into law on July 9, 2012. Seven years on, we review the drugs that have obtained QIDP status, the companies involved, and the clinical trial landscape.

Topic Drug development landscape Drug review

Single report
Trialtrove

Trialtrove 2018 Completed Clinical Trials Snapshot

12 Aug 2019

Get a visual snapshot of how the industry pipelines are faring with our 2018 Completed Trials snapshot. This graphic analysis paints a clear picture of the state of clinical trial completions, while pointing to some important changes that are emerging.

Topic Clinical trials Drug development landscape

Single report
Trialtrove

2018 Completed Trials: State of Industry-Sponsored Clinical Development

06 Aug 2019

The landscape of trials initiated by industry sponsors is one metric that informs about the R&D health of the biopharma industry. Looking specifically at trial completions adds a layer of granularity to the trials landscape and provides valuable perspective on how well industry pipelines are faring. As Informa Pharma has done for the past four years, we report the results from our analysis of the landscape of clinical trials completed during 2018.

Topic Drug development landscape

Single report
Citeline

Clinical Trials State of the Industry Report 2019

30 Jul 2019

KNect365 Life Sciences recently conducted a survey into the clinical trial industry at its most interesting point to date, as organisations are implementing new technologies and trends such as AI, virtual trials and wearables. The final report, based on 214 responses, reveals unique insights into what current benefits and challenges companies are facing in the processes of applying these new approaches to therapeutic development. Citeline introduces the report, exploring what some of the key takeaways mean for the industry.

Topic Drug development landscape

Single report
Citeline

Taking the High Out of Pain: Exploring Abuse-Deterrent Opioids and Opioid Alternatives

03 Jul 2019

With opioid abuse and deaths in the US at an all-time high, the journey to battle the opioid epidemic continues – keeping drug companies and the FDA working hard to come up with effective alternatives for pain.

Topic Drug approval Drug review

View infographic
Citeline, Pharmaprojects

New Active Substances (NAS) LAUNCHED DURING 2018

02 Jul 2019

For a snapshot of the new active substances (NAS) successfully launched last year, download the data-packed New Active Substances (NAS) Launched During 2018 infographic from Citeline.

Topic Drug approval Drug development landscape Drug review

View infographic